Lastly, a head-to-head trial of Saxenda and Wegovy is reviewed
Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes
The findings suggest semaglutide could become an important tool for clinicians treating both CKD and type 2 diabetes, according to Matthew Weir, MD, professor and chief of the division of nephrology at University of Maryland School of Medicine
GLP-2 (TRZ) is commonly used as a research designation for Tirzepatide-related dual agonist peptide studies
Standard Dosing Protocol Compounded semaglutide from Direct Meds is typically administered as a weekly subcutaneous injection
Last Updated: May 2026 This article is updated monthly to reflect the most current case counts, court orders, and settlement developments